The Goldmanchs Group (FRA:GOS) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:GOS The Goldman Sachs Group Inc FRA:GOS
69 GF Score
Price €943.80
GF Value €574.76
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is The Goldmanchs Group Research & Development?

The Goldmanchs Group FRA:GOS -2.14% 69 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:GOS with a GF Score™ of 69/100 and a GF Value™ of €574.76 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. The Goldmanchs Group's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

The Goldmanchs Group  (FRA:GOS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Goldmanchs Group Research & Development Related Terms

The Goldmanchs Group Research & Development Historical Data

* Premium members only.

The historical data trend for The Goldmanchs Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Goldmanchs Group Research & Development Chart

The Goldmanchs Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Goldmanchs Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:GOS
69GF Score
The Goldman Sachs Group Inc FRA:GOS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Goldmanchs Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
The Goldmanchs Group (FRA:GOS) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on The Goldmanchs Group and its competitors.
Is The Goldmanchs Group's Research & Development too high?
The Goldmanchs Group's current Research & Development is €0 Mil. Overall, The Goldmanchs Group has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does The Goldmanchs Group's Research & Development compare to MS and SCHW?
The Goldmanchs Group's Research & Development of €0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The Goldmanchs Group and its competitors. The Goldmanchs Group's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Goldmanchs Group stock overvalued right now?
Based on GuruFocus' analysis, The Goldmanchs Group (FRA:GOS) is currently considered Significantly Overvalued. The stock's GF Value™ is €574.76, compared to a current price of €943.80 — trading 64.2% above its estimated fair value. The current Research & Development is €0 Mil. The Goldmanchs Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The Goldmanchs Group (FRA:GOS), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Goldmanchs Group (FRA:GOS) Overvalued in 2026?

Based on GuruFocus' analysis, The Goldmanchs Group stock appears to be overvalued. The current stock price of €943.80 is trading 64.2% above its estimated GF Value™ of €574.76. GuruFocus considers The Goldmanchs Group to be Significantly Overvalued.

Key valuation signals for FRA:GOS:

  • Research & Development: €0 Mil
  • GF Value™: €574.76 vs. price of €943.80 (64.2% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the FRA:GOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Goldmanchs Group Business Description

Address 200 West Street, New York, NY, USA, 10282
Goldman Sachs is a storied financial institution, founded in 1869 and best known for its role as a leading global investment bank. The firm has a sprawling reach across global financial centers and has been the leading provider of global merger and acquisition advisory services, by revenue, for the past 20 years. Since the global financial crisis, Goldman has expanded its offerings into more stable fee-based businesses like asset and wealth management, which comprised roughly 30% of post-provision revenue at the end of 2025. The firm generates revenue from investment banking, global market making and trading, lending, asset management, wealth management, and a small and declining portfolio of consumer credit card loans.
69GF Score

Get the complete analysis for FRA:GOS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€943.80
Price
€574.76
GF Value